The COVID-19 vaccine from Pfizer/BioNTech has received an emergency authorization in its first market, the UK, following a rapid review of the data by the Medicines and Healthcare products Regulatory Agency. The first vaccinations will be made available to priority recipients starting next week.
UK First To Authorize Pfizer/BioNTech COVID-19 Vaccine
MHRA Flexes Regulatory Muscles In Preparation For New Role
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.
